IN VIVO EFFECTS OF 5‐FLUOROURACIL AND FTORAFUR[1‐(TETRAHYDROFURAN‐2‐YL)‐5‐FLUOROURACIL] ON MURINE MAMMARY TUMORS AND SMALL INTESTINE